Verge Genomics
Leadership Approach Pipeline Partnerships News Careers
LeadershipApproachPipelinePartnershipsNewsCareers
Verge Genomics

Y Combinator spins out biotech on the 'Verge' of genomics-driven drug discovery

Look out, big pharma. The first generation of scientists who came of age during the genomics revolution is transitioning from the classroom to the boardroom, and they're seeking to shake up the industry.

https://www.bioworld.com/articles/369398-y-combinator-spins-out-biotech-on-the-verge-of-genomics-driven-drug-discovery?v=preview

NewsRob MaguireOctober 29, 2015
Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes
Previous

No PhD, “No Fear”: Alice Zhang, 27, Aims Software At Neuro Diseases

NewsRob MaguireJune 6, 2016
Next

Verge Genomics Wants To Cure Neurodegenerative Diseases Through Advanced Algorithms

NewsRob MaguireJuly 15, 2015
  • Home
  • Leadership
  • Approach
  • Pipeline
  • Accessibility
  • Partnerships
  • News
  • Careers
  • Privacy
Verge Genomics Logo

131 Oyster Point Blvd
Suite 300
South San Francisco
CA 94080

  • LinkedIn icon graphic
    X logo icon graphic
  • info@vergegenomics.com
Copyright 2023